Now I have read the paper. Let me compile the updated meta-review based on paper verification.

---

## Summary

GAMA proposes a Learning-to-Improve (L2I) framework for CVRP that encodes the problem instance and current solution as distinct modalities via dual GCNs, then models their intra- and inter-modal interactions through stacked self- and cross-attention layers with a gated fusion mechanism. A PPO-trained policy selects local search operators guided by this rich state embedding. The method is evaluated on synthetic CVRP instances (N=20–100) and zero-shot generalized to the Uchoa benchmark.

---

## Rebuttal Assessment

### Weakness 1: GIRE absent from Table 1 despite being listed in Section 4.2
- **Author's response:** Partially address — Claims GIRE targets the "split-delivery variant," making direct cost comparison infeasible, and commits to adding a footnote in the revision.
- **Assessment:** **Unconvincing** — I verified Section 4.2 directly: it says "Learning to improve methods, including L2I, DACT and GIRE Ma et al. (2023)" with zero qualification. The paper never mentions GIRE uses a different problem formulation; this explanation appears only in the rebuttal. It cannot be credited under the review guidelines (only evidence already in the paper counts). Furthermore, if the formulation truly differs, listing GIRE as a "compared algorithm" in Section 4.2 without qualification is itself an error. The core problem — that the most recent L2I baseline comparison is missing without explanation — is unresolved in the paper.
- **Score impact:** **Weakness unchanged** (Major)

### Weakness 2: Table 2 variance at CVRP100 contradicts the "lower variance" claim
- **Author's response:** Partially address — Argues that "all time budgets" in Section 4.4.2 refers only to CVRP50 (Figure 2), and offers a post-hoc explanation that gated fusion opens a richer landscape at CVRP100, giving both better best costs and higher variance.
- **Assessment:** **Partially convincing** — I verified Section 4.4.2 directly: "We further illustrate this effect in Fig. 2. GAMA exhibits notably lower variance and better median performance across all time budgets." Figure 2 is explicitly captioned as CVRP50. So the author's reading has textual support — the claim is technically anchored to Figure 2's data. However, the prose immediately follows a discussion of CVRP100 mean values (15.7001 vs. 15.6510), making it genuinely ambiguous and inviting misreading. The explanation for the anomalous CVRP100 variance spike (std = 0.0215 vs. ~0.004 for ablations) — that GAMA "opens up a richer landscape" — is plausible given the best cost gap (15.6178 vs. 15.6897) but is in the rebuttal only, absent from the paper. The Wilcoxon significance on means is confirmed in Table 2.
- **Score impact:** **Weakness downgraded** (Major → Minor) — the original reviewer's reading was partially incorrect given Figure 2's explicit CVRP50 caption, but the prose remains misleading and the variance spike is unexplained in the paper.

### Weakness 3: "Significantly outperforms" overclaimed for small instances
- **Author's response:** Partially address — Acknowledges CVRP20 gap is 0.0001 (negligible), commits to revising the abstract in the revision.
- **Assessment:** **Partially convincing** — Verified: Table 1 shows GAMA (6.0810) vs. DACT (6.0811) at CVRP20/T=20k, a 0.0001 difference. The author is honest about the overclaim, but the fix is a promise for revision only, which does not count.
- **Score impact:** **Weakness unchanged** (Minor)

### Weakness 4: Naming slip "proposed GENIS" in Section 4.1
- **Author's response:** Acknowledge — Confirms it's a copy-paste artifact and commits to correction.
- **Assessment:** **Convincing acknowledgment** — Verified: Section 4.1 reads "Table 5 in the appendix gives the parameter settings of the proposed GENIS." This is a genuine error confirmed in the paper.
- **Score impact:** **Weakness unchanged** (Minor) — fixing it requires a revision.

### Weakness 5: GENIS absent from Table 1
- **Author's response:** Partially address — Explains that GENIS was intentionally placed in the ablation (Table 2), but commits to adding it to Table 1 in the revision.
- **Assessment:** **Partially convincing** — The argument that GENIS is a component-level baseline rather than a peer method has some merit. The data in Table 2 does make the contribution visible. However, the promise to add it to Table 1 is again a revision-only fix. The reviewer's point on transparency stands.
- **Score impact:** **Weakness unchanged** (Minor)

### Weakness 6: Framing of classical solvers "deteriorating"
- **Author's response:** Partially address — Acknowledges HGS at CVRP100 achieves 15.6994 in 59s vs. GAMA's 15.6510 in 19m, and the 0.3% advantage at much higher cost. Commits to revising Section 4.3.
- **Assessment:** **Convincing acknowledgment** — The framing issue is verified from Table 1. The author's concession is appropriate.
- **Score impact:** **Weakness unchanged** (Trivial) — revision-only fix.

---

## Strengths

- **Meaningful improvement at CVRP100 under matched budget**: Verified in Table 1 — GAMA achieves avg. cost 15.6510 vs. DACT's 15.6925 and L2I's 15.7334 at T=20k (~0.27% and ~0.53% improvements). Best cost (15.6178) substantially outperforms both DACT (15.6853) and GAMA_NG (15.6897).
- **Ablation with statistical validation**: Table 2 shows a clear ranking GAMA > GAMA_NG > GENIS with Wilcoxon rank-sum tests confirming statistical significance. Both cross-attention and gated fusion contribute independently.
- **Strong zero-shot generalization**: Table 3 shows GAMA achieves 4.956% avg. gap on Uchoa benchmark vs. ReLD's 5.018%, without retraining. GAMA substantially outperforms DACT (25.305%) and L2I (13.557%).
- **Well-specified architecture**: Dual-GCN + cross-attention + gated fusion is fully specified in Eqs. 2–9 with step-by-step description.

---

## Weaknesses

### Fatal
None.

### Major
- **GIRE (Ma et al., 2023) listed in Section 4.2 as compared method but absent from Table 1 with no paper-internal explanation.** The rebuttal's formulation-mismatch explanation is not stated anywhere in the paper and cannot be independently verified from the paper text. Section 4.2 lists GIRE unequivocally as a "Learning to improve method" compared in experiments, yet no results appear and no footnote explains the omission. This is the most critical unresolved issue.

### Minor
- **Abstract's "significantly outperforms" is overclaimed for small instances.** At CVRP20/T=20k the gap is 0.0001 (negligible). No significance tests for Table 1 comparisons. Fix is revision-only.
- **CVRP100 variance anomaly unexplained in the paper.** GAMA's std at CVRP100 (0.0215) is ~5× larger than GAMA_NG (0.0042) and ~18× larger than GAMA's own CVRP50 std (0.0012). While the original reviewer's claim that this contradicts the paper's prose was partially incorrect (Section 4.4.2's lower-variance claim is anchored to Figure 2's CVRP50 data), the phenomenon is real and unaddressed in the paper itself.
- **Naming error "proposed GENIS" in Section 4.1.** Confirmed. Requires revision.
- **GENIS absent from Table 1**, reducing immediate transparency of the marginal contribution.

### Trivial
- **Framing of classical solvers "deteriorating"** is misleading: HGS at CVRP100 achieves 15.6994 in 59s, while GAMA needs 19min (plus 7 days training) for a 0.3% improvement.

---

## Nice-to-Haves
- Operator selection distribution visualization across search phases to directly support the mechanism claims.
- Variance analysis at CVRP100 to explain the best-vs-mean divergence behavior.
- HGS in Table 3 as an absolute quality anchor for the generalization evaluation.
- Extension to TSP or VRPTW to broaden contribution scope.

---

## Novel Insights

GAMA's architectural insight — treating the problem instance graph and the current solution graph as distinct semantic modalities with different topologies, and modeling their interaction via cross-attention rather than concatenation — is a reasonable and principled advance over the GENIS baseline. The empirical evidence in Table 2 demonstrates that gated fusion adds meaningful value beyond simple summed cross-attention (GAMA_NG mean 15.7001 → GAMA mean 15.6510 at CVRP100, statistically significant). The zero-shot generalization result on Uchoa (4.956% avg gap vs. ReLD's 5.018%) is the paper's strongest and most surprising result, suggesting dual-graph multimodal encoding captures transferable structural features more robustly than prior L2I encoders. However, the unexplained combination of lower means and dramatically higher variance at CVRP100 raises questions about the stability of the gating mechanism at scale that remain unaddressed in the current paper.

---

## Suggestions

1. Either include GIRE results in Table 1 or add a clearly stated footnote explaining the exact formulation mismatch (specify which GIRE variant differs and how), ideally with a pointer to GIRE's own benchmark numbers.
2. Add a discussion in Section 4.4.2 explaining the CVRP100 variance spike, either mechanistically or empirically (e.g., trajectory plots of best-vs-mean across runs).
3. Narrow "significantly outperforms" in the abstract to CVRP100, or add significance tests to Table 1.
4. Correct the "proposed GENIS" naming error in Section 4.1 and add a sentence stating GAMA = GENIS + cross-attention + gated fusion.
5. Add GENIS as a row in Table 1.

---

## Score and Decision

**Original score: 4.0 (Weak Reject)**

The rebuttal partially improves the assessment of one major weakness (the variance claim): the reviewer's reading was somewhat incorrect since the prose is technically anchored to Figure 2's CVRP50 data, downgrading that issue from Major to Minor. However, the primary Major weakness — GIRE's absence from Table 1 without any paper-internal explanation — remains fully unresolved. The rebuttal's defense (formulation mismatch) is a post-hoc claim appearing only in the rebuttal, not in the paper, and thus does not count under the review guidelines. All other fixes (abstract revision, naming correction, GENIS in Table 1) are promises for future revision, which similarly do not count. The paper's core contributions (CVRP100 improvement, Uchoa generalization) remain genuine and well-supported, but the incomplete comparison framework and editorial inconsistencies still prevent acceptance.

**Final score: 4.0** — The variance concern downgrade is offset by the fact that the GIRE issue has no resolution in the paper itself. Net change: minimal.

MY FINAL SCORE: <score>4.0</score>
MY FINAL DECISION: <decision>Reject</decision>